Volume 7, Issue 6 (November - December 2022)                   J Obstet Gynecol Cancer Res 2022, 7(6): 530-535 | Back to browse issues page

XML Print

1- Department of Obstetrics and Gynecology, School of Medicine, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran
2- Department of Obstetrics and Gynecology, School of Medicine, Vali Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran
3- Department of Obstetrics and Gynecology, School of Medicine, Vali Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran , shahrzad.sheikhhasani@yahoo.com
Abstract:   (419 Views)

Background & Objective: Cervical cancer is one of the most common cancers in women. One of the most important indicators that deal with all aspects of the patients' health is the Health-related quality of life (QOL). In this study, the QOL of women with cervical cancer in Iran was investigated.
Materials & Methods: The present cross-sectional study examined the QOL of 139 patients with cervical cancer referred to Imam Khomeini hospital, affiliated with the Tehran University of Medical Sciences. For this study, a specific questionnaire of QOL in patients with cervical cancer was used. To determine the predictors of cervical cancer patients, the QOL linear regression model was used.
Results: Findings of this study showed that the total score of QOL of patients was 20.97±1.29. Moreover, in the regression model, a significant relationship was observed between the type of treatment and patients' QOL scores and those patients who had neoadjuvant therapy plus surgery (β=-17.45, P=0.02) and those who received brachytherapy (β=- 14.86 and P=0.09) had a significantly lower QOL score.
Conclusion: Overall, the QOL of people with cervical cancer was moderate. Implementing educational programs for service providers and choosing the appropriate type of treatment according to the stage of the disease and the patient's age can help control this type of disease and its complications and improve the QOL of patients.

Full-Text [PDF 360 kb]   (72 Downloads) |   |   Full-Text (HTML)  (43 Views)  
Systematic Review: Original Research | Subject: Obstetrics and Gynecology
Received: 2022/01/8 | Accepted: 2022/03/3 | Published: 2022/09/9

1. Chase DM, Huang HQ, Wenzel L, Cella D, McQuellon R, Long HJ, et al. Quality of life and survival in advanced cervical cancer: a Gynecologic Oncology Group study. Gynecol Oncol. 2012;125(2):315-9. [DOI:10.1016/j.ygyno.2012.01.047] [PMID]
2. Chun M-S, Lee E-H, Moon S-M, Kang S-H, Ryu H-S. Medical-and-psychosocial factors influencing on the quality of life in patients with cervix cancer. Radiat Oncol J. 2005;23(4):201-10.
3. Fernandes W, Kimura M. Health related quality of life of women with cervical cancer. Rev Lat Am Enfermagem. 2010;18(3):360-7. [DOI:10.1590/S0104-11692010000300010] [PMID]
4. Nasiri S, Sheikh Hasani S, Mousavi A, Modarres Gilani M, Akhavan S, Rahim Vakili MR. Mesonephric Adenocarcinoma of the Cervix Can Be the Same as a Cervical Fibroid: A Case Presentation. J Obstet Gynecol Cancer Res. 2016;1(3):0-. https://doi.org/10.17795/ojcr-8357 [DOI:10.5812/jogcr.62248]
5. Shrestha AD, Neupane D, Vedsted P, Kallestrup P. Cervical cancer prevalence, incidence and mortality in low and middle income countries: a systematic review. Asian Pac J Cancer Prev. 2018;19(2):319. [DOI:10.1111/ecc.13207] [PMID]
6. Watson M, Benard V, Flagg EW. Assessment of trends in cervical cancer screening rates using healthcare claims data: United States, 2003-2014. Preventive medicine reports. 2018;9:124-30. [DOI:10.1016/j.pmedr.2018.01.010] [PMID] [PMCID]
7. Zeng YC, Ching SSY, Loke AY. Quality of life measurement in women with cervical cancer: implications for Chinese cervical cancer survivors. Health Qual Life Outcomes. 2010;8(1):1-9. [DOI:10.1186/1477-7525-8-30] [PMID] [PMCID]
8. Monk BJ, Huang HQ, Cella D, Long Iii HJ. Quality of life outcomes from a randomized phase III trial of cisplatin with or without topotecan in advanced carcinoma of the cervix: a Gynecologic Oncology Group Study. J Clin Oncol. 2005;23(21):4617-25. [DOI:10.1200/JCO.2005.10.522] [PMID]
9. Greimel ER, Winter R, Kapp KS, Haas J. Quality of life and sexual functioning after cervical cancer treatment: A long‐term follow‐up study. J Psychosoc Soc Behav Dimens Cancer. 2009;18(5):476-82. [DOI:10.1002/pon.1426] [PMID]
10. Shirali E, Yarandi F, Behtash N, Hemmatian O. Neoadjuvant chemotherapy in cervical cancer: A review article. J Obstet Gynecol Cancer Res. 2018;3(2):87-91. [DOI:10.30699/jogcr.3.2.87]
11. Greimel E, Kuljanic VK, Waldenstrom A, Duric V, Jensen P, Singer S, et al. European Organization for Research and Treatment of Cancer Quality‐of‐Life Group. The European Organization for Research and Treatment of Cancer (EORTC) Quality‐of‐Life questionnaire cervical cancer module: EORTC QLQ‐CX24. Cancer. 2006;107(8):1812-22. [DOI:10.1002/cncr.22217] [PMID]
12. Wiltink LM, King M, Müller F, Sousa MS, Tang M, Pendlebury A, et al. A systematic review of the impact of contemporary treatment modalities for cervical cancer on women's self-reported health-related quality of life. Support Care Cancer. 2020;28(10):4627-44. [DOI:10.1007/s00520-020-05554-2] [PMID]
13. Rahman Z, Singh U, Qureshi S, Srivastav K, Nishchal A. Assessment of quality of life in treated patients of cancer cervix. J Midlife Health. 2017;8(4):183. [DOI:10.4103/jmh.JMH_40_17] [PMID] [PMCID]
14. Tork Zahrani S, Rastegari L, Khdakarami N, Motlagh Ghanbari A, Akbarzadeh Bagbn ATF, Alireza Quality of life of cervical cancer survivors and its association with clinical and pathological factors. J Adv Nurs Midwifery. 2012;21(75):9-14.
15. Tork Zahrani S, Rastegari L, Khoda Karami N, Mohebbi P. Relationship between quality of life and social support in women treated for cervical cancer. Prev Care Nurs Midwifery J. 2012;1(2):51-7.
16. Bloom JR, Stewart SL, Chang S, Banks PJ. Then and now: quality of life of young breast cancer survivors. Psycho‐Oncology: Journal of the Psychological, Social and Behavioral Dimensions of Cancer. 2004;13(3):147-60. [DOI:10.1002/pon.794] [PMID]
17. Kobayashi K, Morita S, Shimonagayoshi M, Kobayashi M, Fujiki Y, Uchida Y, et al. Effects of socioeconomic factors and cancer survivors' worries on their quality of life (QOL) in Japan. J Psycho Soc Behav Dimens Cancer. 2008;17(6):606-11. [DOI:10.1002/pon.1278] [PMID]
18. Short PF, Mallonee EL. Income disparities in the quality of life of cancer survivors. Med Care. 2006:16-23. [DOI:10.1097/01.mlr.0000188986.84819.3a] [PMID]
19. Huang H-Y, Tsai W-C, Chou W-Y, Hung Y-C, Liu L-C, Huang K-F, et al. Quality of life of breast and cervical cancer survivors. BMC Women's Health. 2017;17(1):1-12. [DOI:10.1186/s12905-017-0387-x] [PMID] [PMCID]
20. Frumovitz M, Obermair A, Coleman RL, Pareja R, Lopez A, Ribero R, et al. Quality of life in patients with cervical cancer after open versus minimally invasive radical hysterectomy (LACC): a secondary outcome of a multicentre, randomised, open-label, phase 3, non-inferiority trial. Lancet Oncol. 2020;21(6):851-60. [DOI:10.1016/S1470-2045(20)30081-4]
21. Dahiya N, Acharya AS, Bachani D, Sharma DN, Gupta S, Haresh KP, et al. Quality of life of patients with advanced cervical cancer before and after chemoradiotherapy. Asian Pac J Cancer Prev. 2016;17(7):3095-9.
22. Pasek M, Suchocka L, Osuch-Pęcak G, Muzykiewicz K, Iwańska E, Kaducakowa H, et al. Longitudinal Health-Related Quality of Life Study among Cervical Cancer Patients Treated with Radiotherapy. J Clin Med. 2021;10(2):226. [DOI:10.3390/jcm10020226] [PMID] [PMCID]
23. Velikova G, Williams LJ, Willis S, Dixon JM, Loncaster J, Hatton M, et al. Quality of life after postmastectomy radiotherapy in patients with intermediate-risk breast cancer (SUPREMO): 2-year follow-up results of a randomised controlled trial. Lancet Oncol. 2018;19(11):1516-29. [DOI:10.1016/S1470-2045(18)30515-1]
24. Goineau A, Campion L, d'Aillières B, Vié B, Ghesquière A, Béra G, et al. Comprehensive Geriatric Assessment and quality of life after localized prostate cancer radiotherapy in elderly patients. PLoS One. 2018;13(4):e0194173. [DOI:10.1371/journal.pone.0194173] [PMID] [PMCID]

Rights and permissions
Creative Commons License Journal of Obstetrics, Gynecology and Cancer Research by Farname Inc is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. Based on a work at http://jogcr.com/.